- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02978963
CBT for Adolescents With Excessive Worry (BiPOro)
Cognitive Behavioral Therapy for Adolescents With Excessive Worry - a Case Series
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot study aims to test a new form of Cognitive Behavioral Therapy for adolescents with excessive worry. The investigators will include 12 participants with excessive worry and test the treatment which focuses on reducing intolerance of uncertainty (IU) in order to reduce worry.
Participants will be randomized to either one, two or three weeks of weekly baseline measurements prior to starting treatment, and will thus work as their on controls in this case series design.
Primary outcome measures will be collected at 12 weeks after treatment start. Participants will be followed up at three months after treatment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 171 77
- Karolinska Institutet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A score on PSWQ-C of at least 22
- Age between 13 and 17 years
- Ability to read and write in Swedish
- A parent or caregiver that is able to co-participate in the treatment
- Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
Exclusion Criteria:
- Diagnosis of autism spectrum disorder, psychosis, bipolar disorder or severe eating disorder
- Present risk of suicide
- Ongoing substance dependence
- Occurrence of domestic violence
- Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Behavioral Therapy
All participants will receive cognitive behavioral therapy for excessive worry.
Focus in treatment will be on reducing participants' intolerance uncertainty through in vivo and imaginary exposure to uncertainty inducing situations and thoughts.
Treatment will also contain psycho education about anxiety and worry, as well as planning for maintenance of treatment gains.
Parents of the participants will receive support and education about worry through an internet-delivered program.
|
CBT focused on reducing intolerance of uncertainty
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Penn State Worry Questionnaire for Children (PSWQ-C)
Time Frame: At 12 weeks after treatment starts
|
Child and parent version
|
At 12 weeks after treatment starts
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
Time Frame: Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Diagnostic interview
|
Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Clinical Global Impression - Severity (CGI-S)
Time Frame: Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Clinician rated severity of symptoms
|
Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Clinical Global Impression - Improvement (CGI-I)
Time Frame: At 12 weeks after start of treatment and three month after treatment has ended.
|
Clinician rated improvement after treatment
|
At 12 weeks after start of treatment and three month after treatment has ended.
|
Children's Global Assessment Scale (CGAS)
Time Frame: Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Clinician rated global functioning
|
Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Brief Intolerance of Uncertainty Scale (Brief IUS)
Time Frame: Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Self rated tolerance to treatment
|
Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Brief Cognitive Avoidance Questionnaire (Brief CAQ)
Time Frame: Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Self rated cognitive avoidance
|
Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Brief Why Worry-II (Brief WW2)
Time Frame: Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Self rated positive assumptions of worry
|
Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Negative Problem Orientation Questionnaire (NPOQ)
Time Frame: Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Self rated negative problem orientation
|
Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended
|
Revised Children´s Anxiety and Depression Scale (RCADS-C)
Time Frame: Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Child and parent version.
|
Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Education, Work and Social Adjustment Scale (EWSAS)
Time Frame: Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Child and parent version.
|
Baseline, 12 weeks after start of treatment and three month after treatment has ended.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EPN DNR 2016/1408-31/5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Excessive Worry
-
Karolinska InstitutetCompleted
-
Karolinska InstitutetCompleted
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioCompletedExcessive WorryCanada
-
Ryerson UniversityCanadian Institutes of Health Research (CIHR); Ministry of Research, Innovation...UnknownExcessive WorryCanada
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioSuspended
-
Karolinska InstitutetCompleted
-
Queen's University, BelfastUniversity College Dublin; Exceed WorldwideCompletedMental Health | Distress, Emotional | WorryCambodia
-
Babes-Bolyai UniversityCompletedPsychological Distress | Worry | Career Decision-making DifficultiesRomania
-
Sandraluz Lara-CinisomoCompletedStress, Depression, Anxiety and WorryUnited States
Clinical Trials on Cognitive behavioral therapy
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway
-
Claremont McKenna CollegeUniversity of California, Los AngelesCompleted
-
University of South FloridaObsessive Compulsive FoundationCompletedObsessive Compulsive Disorder | Stepped Care Cognitive Behavioral TherapyUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
University of PittsburghWithdrawnPsychosis | Prodromal Symptoms | Prodromal Stage | Prodromal StatesUnited States
-
Duke UniversityCompleted
-
The University of Texas Health Science Center at...59th Medical Wing; Brooke Army Medical Center; South Texas Veterans Health Care...CompletedCombat Disorders | Post-Traumatic Stress Disorders | Stress DisordersUnited States
-
University of PittsburghCompletedDepression | Anxiety | Sickle Cell DiseaseUnited States